These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states. Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034 [TBL] [Abstract][Full Text] [Related]
47. Increased proportion of circulating non-22-kilodalton growth hormone isoforms in short children: a possible mechanism for growth failure. Boguszewski CL; Jansson C; Boguszewski MC; Rosberg S; Carlsson B; Albertsson-Wikland K; Carlsson LM J Clin Endocrinol Metab; 1997 Sep; 82(9):2944-9. PubMed ID: 9284724 [TBL] [Abstract][Full Text] [Related]
48. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. Biller BM; Samuels MH; Zagar A; Cook DM; Arafah BM; Bonert V; Stavrou S; Kleinberg DL; Chipman JJ; Hartman ML J Clin Endocrinol Metab; 2002 May; 87(5):2067-79. PubMed ID: 11994342 [TBL] [Abstract][Full Text] [Related]
49. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010. Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215 [TBL] [Abstract][Full Text] [Related]
50. Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer. Hara N; Takizawa I; Isahaya E; Nishiyama T; Hoshii T; Ishizaki F; Takahashi K Urol Oncol; 2012 Sep; 30(5):596-601. PubMed ID: 21458314 [TBL] [Abstract][Full Text] [Related]
51. Automated immunoassay methods for ferritin: recovery studies to assess traceability to an international standard. Blackmore S; Hamilton M; Lee A; Worwood M; Brierley M; Heath A; Thorpe SJ Clin Chem Lab Med; 2008; 46(10):1450-7. PubMed ID: 18844501 [TBL] [Abstract][Full Text] [Related]
52. Standardization of ceruloplasmin measurements is still an issue despite the availability of a common reference material. Infusino I; Valente C; Dolci A; Panteghini M Anal Bioanal Chem; 2010 May; 397(2):521-5. PubMed ID: 19921156 [TBL] [Abstract][Full Text] [Related]
53. The harmonisation of growth hormone measurements: taking the next steps. Wieringa GE; Sturgeon CM; Trainer PJ Clin Chim Acta; 2014 May; 432():68-71. PubMed ID: 24509000 [TBL] [Abstract][Full Text] [Related]
54. The need to revise the cut-off level for the diagnosis of GH deficiency in children. Tenenbaum-Rakover Y Pediatr Endocrinol Rev; 2008 Jun; 5(4):880-8. PubMed ID: 18552750 [TBL] [Abstract][Full Text] [Related]
55. Unaltered ratio of circulating levels of growth hormone/GH isoforms in adults with Prader-Willi syndrome after GHRH plus arginine administration. Rigamonti AE; Grugni G; Marazzi N; Bini S; Bidlingmaier M; Sartorio A Growth Horm IGF Res; 2015 Aug; 25(4):168-73. PubMed ID: 26059749 [TBL] [Abstract][Full Text] [Related]
56. [Report of immunoassay control surveys conducted in the past 30 years by the Subcommittee for Radioisotope in vitro Test, the Medical Science and Pharmaceutical Committee, and the Japan Radioisotope Association]. Odagiri E; Kuwa K; Katakami H; Takeda K; Takeoka K; Hidaka Y; Ieiri T; Ikeda H; Kameko M Rinsho Byori; 2012 Oct; 60(10):932-54. PubMed ID: 23323458 [TBL] [Abstract][Full Text] [Related]